Members Only  |  Contact Us
Twitter   Facebook
AFMR Endowment
National Council
Back to Committees | Back to National Council
Joshua De Leon, MD, Eastern Section Chair-elect
Joshua De Leon, MD
Eastern Section Chair-elect
Joshua De Leon, MD

Current Position: Interventional Cardiologist; Associate Professor, Department of Medicine, NYU Long Island School of Medicine; Director/Coronary Care Unit, NYU Winthrop Hospital, Mineola, NY; Director of Cardiovascular Training Program, NYU Winthrop Hospital.

  • Fellowship in Clinical and Molecular Cardiology, Montefiore Medical Center/Albert Einstein College of Medicine, 1995
  • Residency, Bronx Municipal Hospital Center/Albert Einstein College of Medicine, Internal Medicine, 1991
  • MD from SUNY-Downstate College of Medicine, 1988
Clinical Interest: Dr. DeLeon began and continues to treat patients with all aspects of cardiovascular disease. Over the years, his work has often focused on treatment of acute coronary syndromes.

Research Interest: With background training in molecular genetics, Dr. DeLeon’s research efforts have reflected his interests in understanding the cellular and molecular mechanisms underlying acute coronary syndromes, as well as the more chronic processes underlying atherogenesis.

His most recent research has included extensive collaboration with Dr. Allison Reiss, who directs the Inflammation Section of the division of Vascular Biology at Winthrop. Their work together has been highly productive — bringing mechanistic insight into the disruption of normal cholesterol flux that occurs in diabetes, a very pro-inflammatory state, and one clearly associated with increased cardiovascular risk, for example.

As they continue to work to create a coherent understanding of the mechanisms of how traditional clinical risk factors for atherosclerosis actually confer their risk, Dr. DeLeon’s current work is directed at understanding the role inflammation plays as a final common pathway or as a marker of some other mechanism. Recent work has focused on investigating novel mechanisms of atherogenesis, with an emphasis on examining the role of exosomes. The interdisciplinary team has made great strides toward unraveling the complex interaction between inflammation

Other: Dr. DeLeon is a physician/scientist with 20 years of experience in academic cardiology with extensive experience in clinical research, studying the clinical relevance of inflammatory biomarkers in acute coronary syndromes. With experience in both clinical and molecular research, he has a background conducive to translational work and has had the opportunity of taking advantage of that experience at Winthrop.

Current AFMR position: Eastern Section Chair-elect

Term: 05/01/22 – 04/30/23

Quick Links
About AFMR
Meetings & Education
Get Involved
Members Only